Autopsy report · NCT00159211

Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“inclusion was finished”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months after it had already started.
Ran for about 2 years before it stopped.
28 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor type: University, hospital or other
Conditions: Type 2 Diabetes
Interventions: UMULINE NPH; pioglitazone
Participants: 28
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.